Unfortunately most of the brothers are under 50 and not eligible for AstraZenaca with a minimal risk of blood clotting side effects. Pfizer/BioNTech is now in short supply throughout the World. In hindsight, the Federal Government should have put their bets on Pfizer/BioNTech rather than AstraZenaca.